401k Plan data: ENVISION PHARMA, INC. 401(K) PLAN plan

ENVISION PHARMA, INC. 401(K) PLAN 401k Plan overview

Plan Name	ENVISION PHARMA, INC. 401(K) PLAN
Plan identification number	001

ENVISION PHARMA, INC. 401(K) PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Participant-directed brokerage accounts provided as an investment option under the plan.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Master plan - A pension plan that is made available by a sponsor for adoption by employers; that is the subject of a favorable opinion letter; and for which a single funding medium (for example, a trust or custodial account) is established for the joint use of all adopting employers.

401k Sponsoring company profile

ENVISION PHARMA, INC. has sponsored the creation of one or more 401k plans.

Company Name: ENVISION PHARMA, INC.

Employer identification number (EIN): 061633253

NAIC Classification: 541990
NAIC Description: All Other Professional, Scientific, and Technical Services

Additional information about ENVISION PHARMA, INC.

Jurisdiction of Incorporation: Vermont Secretary of State Corporations Division

Incorporation Date: 2015-01-30

Company Identification Number: 299294

Legal Registered Office Address: 100 NORTH MAIN STREET
SUITE 2
BARRE
United States of America (USA)
05641

More information about ENVISION PHARMA, INC.

Form 5500 Filing Information

Submission information for form 5500 for 401k plan ENVISION PHARMA, INC. 401(K) PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2022-01-01
001 2021-01-01
001 2020-01-01
001 2019-01-01
001 2018-01-01
001 2017-01-01 CARRIE KRAJCIK
001 2016-01-01 CARRIE KRAJCIK
001 2016-01-01 CARRIE KRAJCIK
001 2015-01-01 CARRIE KRAJCIK
001 2014-01-01 CARRIE KRAJCIK
001 2014-01-01 CARRIE KRAJCIK
001 2013-08-01 CARRIE KRAJCIK

Plan Statistics for ENVISION PHARMA, INC. 401(K) PLAN

401k plan membership statisitcs for ENVISION PHARMA, INC. 401(K) PLAN

Measure Date Value
2022: ENVISION PHARMA, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year 2022-01-01 798
Total number of active participants reported on line 7a of the Form 5500 2022-01-01 813
Number of retired or separated participants receiving benefits 2022-01-01 0
Number of other retired or separated participants entitled to future benefits 2022-01-01 148
Total of all active and inactive participants 2022-01-01 961
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2022-01-01 1
Total participants 2022-01-01 962
Number of participants with account balances 2022-01-01 842
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2022-01-01 18
2021: ENVISION PHARMA, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year 2021-01-01 500
Total number of active participants reported on line 7a of the Form 5500 2021-01-01 494
Number of retired or separated participants receiving benefits 2021-01-01 0
Number of other retired or separated participants entitled to future benefits 2021-01-01 109
Total of all active and inactive participants 2021-01-01 603
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2021-01-01 1
Total participants 2021-01-01 604
Number of participants with account balances 2021-01-01 523
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2021-01-01 0
2020: ENVISION PHARMA, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year 2020-01-01 489
Total number of active participants reported on line 7a of the Form 5500 2020-01-01 416
Number of retired or separated participants receiving benefits 2020-01-01 0
Number of other retired or separated participants entitled to future benefits 2020-01-01 76
Total of all active and inactive participants 2020-01-01 492
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2020-01-01 1
Total participants 2020-01-01 493
Number of participants with account balances 2020-01-01 438
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2020-01-01 0
2019: ENVISION PHARMA, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 452
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 418
Number of retired or separated participants receiving benefits 2019-01-01 0
Number of other retired or separated participants entitled to future benefits 2019-01-01 63
Total of all active and inactive participants 2019-01-01 481
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 1
Total participants 2019-01-01 482
Number of participants with account balances 2019-01-01 427
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 0
2018: ENVISION PHARMA, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 386
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 406
Number of retired or separated participants receiving benefits 2018-01-01 0
Number of other retired or separated participants entitled to future benefits 2018-01-01 45
Total of all active and inactive participants 2018-01-01 451
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 1
Total participants 2018-01-01 452
Number of participants with account balances 2018-01-01 386
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 0
2017: ENVISION PHARMA, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 338
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 350
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 28
Total of all active and inactive participants 2017-01-01 378
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 1
Total participants 2017-01-01 379
Number of participants with account balances 2017-01-01 328
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 0
2016: ENVISION PHARMA, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 251
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 320
Number of retired or separated participants receiving benefits 2016-01-01 0
Number of other retired or separated participants entitled to future benefits 2016-01-01 16
Total of all active and inactive participants 2016-01-01 336
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 0
Total participants 2016-01-01 336
Number of participants with account balances 2016-01-01 279
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 0
2015: ENVISION PHARMA, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 230
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 226
Number of retired or separated participants receiving benefits 2015-01-01 0
Number of other retired or separated participants entitled to future benefits 2015-01-01 20
Total of all active and inactive participants 2015-01-01 246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 0
Total participants 2015-01-01 246
Number of participants with account balances 2015-01-01 216
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 0
2014: ENVISION PHARMA, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 194
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 206
Number of retired or separated participants receiving benefits 2014-01-01 0
Number of other retired or separated participants entitled to future benefits 2014-01-01 21
Total of all active and inactive participants 2014-01-01 227
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 227
Number of participants with account balances 2014-01-01 201
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 0
2013: ENVISION PHARMA, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year 2013-08-01 170
Total number of active participants reported on line 7a of the Form 5500 2013-08-01 177
Number of retired or separated participants receiving benefits 2013-08-01 0
Number of other retired or separated participants entitled to future benefits 2013-08-01 18
Total of all active and inactive participants 2013-08-01 195
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-08-01 0
Total participants 2013-08-01 195
Number of participants with account balances 2013-08-01 168
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-08-01 0

Measure	Date	Value
2022: ENVISION PHARMA, INC. 401(K) PLAN 2022 401k membership
Total participants, beginning-of-year	2022-01-01	798
Total number of active participants reported on line 7a of the Form 5500	2022-01-01	813
Number of retired or separated participants receiving benefits	2022-01-01	0
Number of other retired or separated participants entitled to future benefits	2022-01-01	148
Total of all active and inactive participants	2022-01-01	961
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2022-01-01	1
Total participants	2022-01-01	962
Number of participants with account balances	2022-01-01	842
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2022-01-01	18
2021: ENVISION PHARMA, INC. 401(K) PLAN 2021 401k membership
Total participants, beginning-of-year	2021-01-01	500
Total number of active participants reported on line 7a of the Form 5500	2021-01-01	494
Number of retired or separated participants receiving benefits	2021-01-01	0
Number of other retired or separated participants entitled to future benefits	2021-01-01	109
Total of all active and inactive participants	2021-01-01	603
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2021-01-01	1
Total participants	2021-01-01	604
Number of participants with account balances	2021-01-01	523
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2021-01-01	0
2020: ENVISION PHARMA, INC. 401(K) PLAN 2020 401k membership
Total participants, beginning-of-year	2020-01-01	489
Total number of active participants reported on line 7a of the Form 5500	2020-01-01	416
Number of retired or separated participants receiving benefits	2020-01-01	0
Number of other retired or separated participants entitled to future benefits	2020-01-01	76
Total of all active and inactive participants	2020-01-01	492
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2020-01-01	1
Total participants	2020-01-01	493
Number of participants with account balances	2020-01-01	438
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2020-01-01	0
2019: ENVISION PHARMA, INC. 401(K) PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	452
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	418
Number of retired or separated participants receiving benefits	2019-01-01	0
Number of other retired or separated participants entitled to future benefits	2019-01-01	63
Total of all active and inactive participants	2019-01-01	481
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	1
Total participants	2019-01-01	482
Number of participants with account balances	2019-01-01	427
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	0
2018: ENVISION PHARMA, INC. 401(K) PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	386
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	406
Number of retired or separated participants receiving benefits	2018-01-01	0
Number of other retired or separated participants entitled to future benefits	2018-01-01	45
Total of all active and inactive participants	2018-01-01	451
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	1
Total participants	2018-01-01	452
Number of participants with account balances	2018-01-01	386
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	0
2017: ENVISION PHARMA, INC. 401(K) PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	338
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	350
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	28
Total of all active and inactive participants	2017-01-01	378
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	1
Total participants	2017-01-01	379
Number of participants with account balances	2017-01-01	328
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	0
2016: ENVISION PHARMA, INC. 401(K) PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	251
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	320
Number of retired or separated participants receiving benefits	2016-01-01	0
Number of other retired or separated participants entitled to future benefits	2016-01-01	16
Total of all active and inactive participants	2016-01-01	336
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	0
Total participants	2016-01-01	336
Number of participants with account balances	2016-01-01	279
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	0
2015: ENVISION PHARMA, INC. 401(K) PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	230
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	226
Number of retired or separated participants receiving benefits	2015-01-01	0
Number of other retired or separated participants entitled to future benefits	2015-01-01	20
Total of all active and inactive participants	2015-01-01	246
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	0
Total participants	2015-01-01	246
Number of participants with account balances	2015-01-01	216
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	0
2014: ENVISION PHARMA, INC. 401(K) PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	194
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	206
Number of retired or separated participants receiving benefits	2014-01-01	0
Number of other retired or separated participants entitled to future benefits	2014-01-01	21
Total of all active and inactive participants	2014-01-01	227
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	227
Number of participants with account balances	2014-01-01	201
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	0
2013: ENVISION PHARMA, INC. 401(K) PLAN 2013 401k membership
Total participants, beginning-of-year	2013-08-01	170
Total number of active participants reported on line 7a of the Form 5500	2013-08-01	177
Number of retired or separated participants receiving benefits	2013-08-01	0
Number of other retired or separated participants entitled to future benefits	2013-08-01	18
Total of all active and inactive participants	2013-08-01	195
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-08-01	0
Total participants	2013-08-01	195
Number of participants with account balances	2013-08-01	168
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-08-01	0

Financial Data on ENVISION PHARMA, INC. 401(K) PLAN

Measure	Date	Value
2022 : ENVISION PHARMA, INC. 401(K) PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets	2022-12-31	$0
Total transfer of assets to this plan	2022-12-31	$11,043,365
Total transfer of assets from this plan	2022-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$27
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2022-12-31	$14,722
Total income from all sources (including contributions)	2022-12-31	$-546,540
Total loss/gain on sale of assets	2022-12-31	$0
Total of all expenses incurred	2022-12-31	$7,743,415
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2022-12-31	$7,544,375
Value of total corrective distributions	2022-12-31	$1,205
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2022-12-31	$10,787,880
Value of total assets at end of year	2022-12-31	$59,213,238
Value of total assets at beginning of year	2022-12-31	$56,474,523
Total of administrative expenses incurred including professional, contract, advisory and management fees	2022-12-31	$197,835
Total interest from all sources	2022-12-31	$8,904
Total dividends received (eg from common stock, registered investment company shares)	2022-12-31	$2,769,667
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2022-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2022-12-31	$2,769,667
Was this plan covered by a fidelity bond	2022-12-31	Yes
Value of fidelity bond cover	2022-12-31	$500,000
If this is an individual account plan, was there a blackout period	2022-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2022-12-31	No
Contributions received from participants	2022-12-31	$6,670,419
Participant contributions at end of year	2022-12-31	$252,160
Participant contributions at beginning of year	2022-12-31	$151,985
Assets. Other investments not covered elsewhere at end of year	2022-12-31	$67,726
Assets. Other investments not covered elsewhere at beginning of year	2022-12-31	$115,423
Income. Received or receivable in cash from other sources (including rollovers)	2022-12-31	$1,638,682
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2022-12-31	$27
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2022-12-31	$14,722
Other income not declared elsewhere	2022-12-31	$67,778
Administrative expenses (other) incurred	2022-12-31	$197,835
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Value of net income/loss	2022-12-31	$-8,289,955
Value of net assets at end of year (total assets less liabilities)	2022-12-31	$59,213,211
Value of net assets at beginning of year (total assets less liabilities)	2022-12-31	$56,459,801
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2022-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2022-12-31	No
Were any leases to which the plan was party in default or uncollectible	2022-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2022-12-31	$55,799,588
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2022-12-31	$53,129,726
Interest on participant loans	2022-12-31	$8,904
Value of interest in common/collective trusts at end of year	2022-12-31	$3,093,764
Value of interest in common/collective trusts at beginning of year	2022-12-31	$3,077,389
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2022-12-31	$-14,246,286
Net investment gain or loss from common/collective trusts	2022-12-31	$65,517
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2022-12-31	No
Was there a failure to transmit to the plan any participant contributions	2022-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2022-12-31	No
Contributions received in cash from employer	2022-12-31	$2,478,779
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2022-12-31	$7,544,375
Did the plan have assets held for investment	2022-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2022-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2022-12-31	No
Opinion of an independent qualified public accountant for this plan	2022-12-31	Unqualified
Accountancy firm name	2022-12-31	VISCONTI & ASSOCIATES P.C
Accountancy firm EIN	2022-12-31	061354191
2021 : ENVISION PHARMA, INC. 401(K) PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets	2021-12-31	$0
Total transfer of assets to this plan	2021-12-31	$0
Total transfer of assets from this plan	2021-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$14,722
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2021-12-31	$23
Total income from all sources (including contributions)	2021-12-31	$15,826,529
Total loss/gain on sale of assets	2021-12-31	$0
Total of all expenses incurred	2021-12-31	$10,291,504
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2021-12-31	$10,111,365
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2021-12-31	$8,392,507
Value of total assets at end of year	2021-12-31	$56,474,523
Value of total assets at beginning of year	2021-12-31	$50,924,799
Total of administrative expenses incurred including professional, contract, advisory and management fees	2021-12-31	$180,139
Total interest from all sources	2021-12-31	$9,351
Total dividends received (eg from common stock, registered investment company shares)	2021-12-31	$2,795,599
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2021-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2021-12-31	$2,795,599
Was this plan covered by a fidelity bond	2021-12-31	Yes
Value of fidelity bond cover	2021-12-31	$500,000
If this is an individual account plan, was there a blackout period	2021-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2021-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2021-12-31	No
Contributions received from participants	2021-12-31	$4,075,053
Participant contributions at end of year	2021-12-31	$151,985
Participant contributions at beginning of year	2021-12-31	$238,494
Assets. Other investments not covered elsewhere at end of year	2021-12-31	$115,423
Assets. Other investments not covered elsewhere at beginning of year	2021-12-31	$85,496
Income. Received or receivable in cash from other sources (including rollovers)	2021-12-31	$2,764,982
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2021-12-31	$14,722
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2021-12-31	$23
Other income not declared elsewhere	2021-12-31	$150,156
Administrative expenses (other) incurred	2021-12-31	$180,139
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Value of net income/loss	2021-12-31	$5,535,025
Value of net assets at end of year (total assets less liabilities)	2021-12-31	$56,459,801
Value of net assets at beginning of year (total assets less liabilities)	2021-12-31	$50,924,776
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2021-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2021-12-31	No
Were any leases to which the plan was party in default or uncollectible	2021-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2021-12-31	$53,129,726
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2021-12-31	$48,151,106
Interest on participant loans	2021-12-31	$9,351
Value of interest in common/collective trusts at end of year	2021-12-31	$3,077,389
Value of interest in common/collective trusts at beginning of year	2021-12-31	$2,449,703
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2021-12-31	$4,425,566
Net investment gain or loss from common/collective trusts	2021-12-31	$53,350
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2021-12-31	No
Was there a failure to transmit to the plan any participant contributions	2021-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2021-12-31	No
Contributions received in cash from employer	2021-12-31	$1,552,472
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2021-12-31	$10,111,365
Did the plan have assets held for investment	2021-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2021-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2021-12-31	No
Opinion of an independent qualified public accountant for this plan	2021-12-31	Unqualified
Accountancy firm name	2021-12-31	VISCONTI & ASSOCIATES P.C
Accountancy firm EIN	2021-12-31	061354191
2020 : ENVISION PHARMA, INC. 401(K) PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets	2020-12-31	$0
Total transfer of assets to this plan	2020-12-31	$0
Total transfer of assets from this plan	2020-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$23
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2020-12-31	$0
Total income from all sources (including contributions)	2020-12-31	$13,579,544
Total loss/gain on sale of assets	2020-12-31	$0
Total of all expenses incurred	2020-12-31	$2,253,431
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2020-12-31	$2,139,460
Expenses. Certain deemed distributions of participant loans	2020-12-31	$1
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2020-12-31	$5,928,478
Value of total assets at end of year	2020-12-31	$50,924,799
Value of total assets at beginning of year	2020-12-31	$39,598,663
Total of administrative expenses incurred including professional, contract, advisory and management fees	2020-12-31	$113,970
Total interest from all sources	2020-12-31	$16,762
Total dividends received (eg from common stock, registered investment company shares)	2020-12-31	$1,945,437
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2020-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2020-12-31	$1,945,429
Was this plan covered by a fidelity bond	2020-12-31	Yes
Value of fidelity bond cover	2020-12-31	$500,000
If this is an individual account plan, was there a blackout period	2020-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2020-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2020-12-31	No
Contributions received from participants	2020-12-31	$3,793,916
Participant contributions at end of year	2020-12-31	$238,494
Participant contributions at beginning of year	2020-12-31	$363,910
Assets. Other investments not covered elsewhere at end of year	2020-12-31	$85,496
Income. Received or receivable in cash from other sources (including rollovers)	2020-12-31	$644,847
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2020-12-31	$23
Other income not declared elsewhere	2020-12-31	$133,182
Administrative expenses (other) incurred	2020-12-31	$113,970
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Value of net income/loss	2020-12-31	$11,326,113
Value of net assets at end of year (total assets less liabilities)	2020-12-31	$50,924,776
Value of net assets at beginning of year (total assets less liabilities)	2020-12-31	$39,598,663
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2020-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2020-12-31	No
Were any leases to which the plan was party in default or uncollectible	2020-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2020-12-31	$48,151,106
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2020-12-31	$39,234,753
Interest on participant loans	2020-12-31	$16,762
Value of interest in common/collective trusts at end of year	2020-12-31	$2,449,703
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2020-12-31	$5,534,538
Net investment gain or loss from common/collective trusts	2020-12-31	$21,147
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2020-12-31	No
Was there a failure to transmit to the plan any participant contributions	2020-12-31	No
Has the plan failed to provide any benefit when due under the plan	2020-12-31	No
Contributions received in cash from employer	2020-12-31	$1,489,715
Income. Dividends from common stock	2020-12-31	$8
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2020-12-31	$2,139,460
Did the plan have assets held for investment	2020-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2020-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2020-12-31	No
Opinion of an independent qualified public accountant for this plan	2020-12-31	Disclaimer
Accountancy firm name	2020-12-31	VISCONTI & ASSOCIATES, P.C
Accountancy firm EIN	2020-12-31	061354191
2019 : ENVISION PHARMA, INC. 401(K) PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$0
Total transfer of assets from this plan	2019-12-31	$173
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$12,532,745
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$1,557,985
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$1,486,706
Expenses. Certain deemed distributions of participant loans	2019-12-31	$61
Value of total corrective distributions	2019-12-31	$1,327
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$5,146,250
Value of total assets at end of year	2019-12-31	$39,598,663
Value of total assets at beginning of year	2019-12-31	$28,624,076
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$69,891
Total interest from all sources	2019-12-31	$19,607
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$2,326,724
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$2,326,724
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$500,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2019-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$3,455,324
Participant contributions at end of year	2019-12-31	$363,910
Participant contributions at beginning of year	2019-12-31	$325,833
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$295,472
Other income not declared elsewhere	2019-12-31	$90,650
Administrative expenses (other) incurred	2019-12-31	$69,891
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Value of net income/loss	2019-12-31	$10,974,760
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$39,598,663
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$28,624,076
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$39,234,753
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$28,298,243
Interest on participant loans	2019-12-31	$19,607
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$4,949,514
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Contributions received in cash from employer	2019-12-31	$1,395,454
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$1,486,706
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	VISCONTI & ASSOCIATES, P.C
Accountancy firm EIN	2019-12-31	061354191
2018 : ENVISION PHARMA, INC. 401(K) PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total transfer of assets from this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$3,347,068
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$2,187,161
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$2,126,427
Expenses. Certain deemed distributions of participant loans	2018-12-31	$59
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$5,526,092
Value of total assets at end of year	2018-12-31	$28,624,076
Value of total assets at beginning of year	2018-12-31	$27,464,169
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$60,675
Total interest from all sources	2018-12-31	$14,607
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$2,577,412
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$2,577,412
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$500,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2018-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$3,211,036
Participant contributions at end of year	2018-12-31	$325,833
Participant contributions at beginning of year	2018-12-31	$263,659
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$999,705
Other income not declared elsewhere	2018-12-31	$79,707
Administrative expenses (other) incurred	2018-12-31	$60,675
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Value of net income/loss	2018-12-31	$1,159,907
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$28,624,076
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$27,464,169
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$28,298,243
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$27,200,510
Interest on participant loans	2018-12-31	$14,607
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-4,850,750
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Contributions received in cash from employer	2018-12-31	$1,315,351
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$2,126,427
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	VISCONTI & ASSOCIATES, P.C
Accountancy firm EIN	2018-12-31	061354191
2017 : ENVISION PHARMA, INC. 401(K) PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$0
Total transfer of assets from this plan	2017-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$8,848,051
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$783,024
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$737,457
Expenses. Certain deemed distributions of participant loans	2017-12-31	$142
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$4,787,358
Value of total assets at end of year	2017-12-31	$27,464,169
Value of total assets at beginning of year	2017-12-31	$19,399,142
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$45,425
Total interest from all sources	2017-12-31	$5,614
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$1,468,659
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$1,468,659
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$500,000
If this is an individual account plan, was there a blackout period	2017-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2017-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$2,725,732
Participant contributions at end of year	2017-12-31	$263,659
Participant contributions at beginning of year	2017-12-31	$80,942
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$947,742
Other income not declared elsewhere	2017-12-31	$59,864
Administrative expenses (other) incurred	2017-12-31	$45,425
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Value of net income/loss	2017-12-31	$8,065,027
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$27,464,169
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$19,399,142
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$27,200,510
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$19,318,200
Interest on participant loans	2017-12-31	$5,614
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$2,526,556
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Contributions received in cash from employer	2017-12-31	$1,113,884
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$737,457
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	VISCONTI & ASSOCIATES, P.C
Accountancy firm EIN	2017-12-31	061354191
2016 : ENVISION PHARMA, INC. 401(K) PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$0
Total transfer of assets from this plan	2016-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$4,659,186
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$921,220
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$868,811
Expenses. Certain deemed distributions of participant loans	2016-12-31	$17,677
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$3,487,781
Value of total assets at end of year	2016-12-31	$19,399,142
Value of total assets at beginning of year	2016-12-31	$15,661,176
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$34,732
Total interest from all sources	2016-12-31	$4,865
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$796,104
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$796,104
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$500,000
If this is an individual account plan, was there a blackout period	2016-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$2,358,656
Participant contributions at end of year	2016-12-31	$80,942
Participant contributions at beginning of year	2016-12-31	$143,250
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$156,186
Other income not declared elsewhere	2016-12-31	$46,191
Administrative expenses (other) incurred	2016-12-31	$34,732
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$3,737,966
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$19,399,142
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$15,661,176
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$19,318,200
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$15,517,926
Interest on participant loans	2016-12-31	$4,865
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$324,245
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$972,939
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$868,811
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	HOPE & HERNANDEZ, PC
Accountancy firm EIN	2016-12-31	060993320
2015 : ENVISION PHARMA, INC. 401(K) PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets to this plan	2015-12-31	$0
Total transfer of assets from this plan	2015-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total income from all sources (including contributions)	2015-12-31	$2,731,277
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$1,262,029
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$1,230,396
Expenses. Certain deemed distributions of participant loans	2015-12-31	$302
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$2,826,625
Value of total assets at end of year	2015-12-31	$15,661,176
Value of total assets at beginning of year	2015-12-31	$14,191,928
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$31,331
Total interest from all sources	2015-12-31	$6,348
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$885,640
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$885,640
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$500,000
If this is an individual account plan, was there a blackout period	2015-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$1,842,713
Participant contributions at end of year	2015-12-31	$143,250
Participant contributions at beginning of year	2015-12-31	$166,448
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$207,744
Other income not declared elsewhere	2015-12-31	$41,592
Administrative expenses (other) incurred	2015-12-31	$31,331
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$1,469,248
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$15,661,176
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$14,191,928
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$15,517,926
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$14,025,480
Interest on participant loans	2015-12-31	$6,348
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-1,028,928
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	No
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$776,168
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$1,230,396
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	HOPE & HERNANDEZ, PC
Accountancy firm EIN	2015-12-31	060993320
2014 : ENVISION PHARMA, INC. 401(K) PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets to this plan	2014-12-31	$0
Total transfer of assets from this plan	2014-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$3,113,110
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$259,143
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$231,726
Expenses. Certain deemed distributions of participant loans	2014-12-31	$567
Value of total corrective distributions	2014-12-31	$1,303
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$2,529,312
Value of total assets at end of year	2014-12-31	$14,191,928
Value of total assets at beginning of year	2014-12-31	$11,337,961
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$25,547
Total interest from all sources	2014-12-31	$5,657
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$940,772
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$940,772
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$500,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$1,556,466
Participant contributions at end of year	2014-12-31	$166,448
Participant contributions at beginning of year	2014-12-31	$122,714
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$304,168
Other income not declared elsewhere	2014-12-31	$32,975
Administrative expenses (other) incurred	2014-12-31	$25,547
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$2,853,967
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$14,191,928
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$11,337,961
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$14,025,480
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$11,215,247
Interest on participant loans	2014-12-31	$5,657
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$-395,606
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	No
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$668,678
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$231,726
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Qualified
Accountancy firm name	2014-12-31	HOPE & HERNANDEZ, PC
Accountancy firm EIN	2014-12-31	060993320
2013 : ENVISION PHARMA, INC. 401(K) PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total transfer of assets to this plan	2013-12-31	$9,634,848
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$1,941,637
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$238,524
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$227,509
Expenses. Certain deemed distributions of participant loans	2013-12-31	$7,165
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$1,095,719
Value of total assets at end of year	2013-12-31	$11,337,961
Value of total assets at beginning of year	2013-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$3,850
Total interest from all sources	2013-12-31	$1,260
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$414,485
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$414,485
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$1,000
If this is an individual account plan, was there a blackout period	2013-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$593,208
Participant contributions at end of year	2013-12-31	$122,714
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$193,063
Other income not declared elsewhere	2013-12-31	$4,410
Administrative expenses (other) incurred	2013-12-31	$3,850
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$1,703,113
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$11,337,961
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$11,215,247
Interest on participant loans	2013-12-31	$1,260
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$425,763
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$309,448
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$227,509
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2013-12-31	Yes
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No

Form 5500 Responses for ENVISION PHARMA, INC. 401(K) PLAN

2022: ENVISION PHARMA, INC. 401(K) PLAN 2022 form 5500 responses
2022-01-01	Type of plan entity	Single employer plan
2022-01-01	Submission has been amended	No
2022-01-01	This submission is the final filing	No
2022-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2022-01-01	Plan is a collectively bargained plan	No
2022-01-01	Plan funding arrangement – Trust	Yes
2022-01-01	Plan benefit arrangement - Trust	Yes
2021: ENVISION PHARMA, INC. 401(K) PLAN 2021 form 5500 responses
2021-01-01	Type of plan entity	Single employer plan
2021-01-01	Submission has been amended	No
2021-01-01	This submission is the final filing	No
2021-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2021-01-01	Plan is a collectively bargained plan	No
2021-01-01	Plan funding arrangement – Trust	Yes
2021-01-01	Plan benefit arrangement - Trust	Yes
2020: ENVISION PHARMA, INC. 401(K) PLAN 2020 form 5500 responses
2020-01-01	Type of plan entity	Single employer plan
2020-01-01	Submission has been amended	No
2020-01-01	This submission is the final filing	No
2020-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2020-01-01	Plan is a collectively bargained plan	No
2020-01-01	Plan funding arrangement – Trust	Yes
2020-01-01	Plan benefit arrangement - Trust	Yes
2019: ENVISION PHARMA, INC. 401(K) PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	No
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: ENVISION PHARMA, INC. 401(K) PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	No
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: ENVISION PHARMA, INC. 401(K) PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	No
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: ENVISION PHARMA, INC. 401(K) PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	No
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: ENVISION PHARMA, INC. 401(K) PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	No
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: ENVISION PHARMA, INC. 401(K) PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	Yes
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	No
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: ENVISION PHARMA, INC. 401(K) PLAN 2013 form 5500 responses
2013-08-01	Type of plan entity	Single employer plan
2013-08-01	First time form 5500 has been submitted	Yes
2013-08-01	Submission has been amended	No
2013-08-01	This submission is the final filing	No
2013-08-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2013-08-01	Plan is a collectively bargained plan	No
2013-08-01	Plan funding arrangement – Trust	Yes
2013-08-01	Plan benefit arrangement - Trust	Yes

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	ENVISION PHARMA, INC.
Employer identification number (EIN):	061633253
NAIC Classification:	541990
NAIC Description:	All Other Professional, Scientific, and Technical Services

Jurisdiction of Incorporation:	Vermont Secretary of State Corporations Division
Incorporation Date:	2015-01-30
Company Identification Number:	299294
Legal Registered Office Address:	100 NORTH MAIN STREET SUITE 2 BARRE United States of America (USA) 05641